T2D patients often exhibit chronically elevated levels of circulating lipopolysaccharide-binding protein (LBP) and soluble CD14, biomarkers that signal sustained low-grade endotoxemia [225,226]. The gene discussed is LBP; the disease is serum lipopolysaccharide activity.